Intersting article:
Direct Medical Costs of Bronchiolitis Hospitalizations in the United States
http://pediatrics.aappublications.org/content/118/6/2418
RESULTS. In 2002, an estimated 149000 patients were hospitalized with bronchiolitis. Frequency of hospitalizations was higher among children age <1 year of age, male gender, and nonwhite race. Mean length of stay was 3.3 days. Total annual costs for bronchiolitis-related hospitalizations were $543 million, with a mean cost of $3799 per hospitalization. Mean cost of bronchiolitis with a codiagnosis of pneumonia was $6191. In a multivariate analysis controlling for 3 confounding factors (including length of stay), cost per hospitalization was higher for children ≥1 year and lower for those in the South versus Northeast.
CONCLUSIONS. Bronchiolitis admissions cost more than $500 million annually. A codiagnosis of bronchiolitis and pneumonia almost doubles the cost of the hospitalization. Inpatient health care costs of bronchiolitis are higher than estimated previously and highlight the need for initiatives to safely reduce bronchiolitis hospitalizations and thereby decrease health care costs.
Any reason why we can't monetise the positive results in relation to Bronchiolitis?
- Forums
- ASX - By Stock
- RAP
- Conference Call Summary
Conference Call Summary, page-334
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
-
- There are more pages in this discussion • 243 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAP (ASX) to my watchlist
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online